| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a6911fbf1d120a893f2fdc32c17cc3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afbf74f1f21f29cab72c82a61e54284e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_352dcc674cada600c94b4144b9eaa99b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b13a60dc19709f8ea947dbf08cc2fd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ae82682fcc04063d83ca293ec8c2b54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41abe8307a25c6e8f0997e9e7f098670
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7416d81e903982c257c558ee95ef59c0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2012-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f05e7a808867740b5f96faa2c4745ec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e7c6c6a684be05f7ae7d789bb003524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2b3bb37ae0930447c7e7ffdf99c6627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e653126345fcb1852e5bbb934ca2495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d96d059edeaa4e888e77b1ee62dbc49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48432bb528faf18eff620bf7011660c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd9ddce0de96f9e665c8ad16aa561675 |
| publicationDate |
2016-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9506926-B2 |
| titleOfInvention |
Molecular predictors of therapeutic response to specific anti-cancer agents |
| abstract |
Herein is described the use of a collection of 50 breast cancer cell lines to match responses to 77 conventional and experimental therapeutic agents with transcriptional, proteomic and genomic subtypes found in primary tumors. Almost all compounds produced strong differential responses across the cell lines produced responses that were associated with transcriptional and proteomic subtypes and produced responses that were associated with recurrent genome copy number abnormalities. These associations can now be incorporated into clinical trials that test subtype markers and clinical responses simultaneously. |
| priorityDate |
2011-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |